Biotechnology Information Institute

Biotechnology Information Institute

Our IP is For Sale! This includes the domain names BIOPHARMA.com, BIOPHARMA.org, the BIOPHARMA® U.S. Trademark, and >100 other 'BIOPHARMA(ceutical)' industry domains.

The Biotechnology Information Institute (BII) develops unique, high-end information resources and provides consulting serving critical needs of the biotechnology and pharmaceutical communities, particularly concerning biopharmaceuticals and their manufacturing (bioprocessing). As a sole proprietorship, Ronald A. Rader, President, is responsible for all of BII's products and services. More recent products and projects include:

BIOPHARMA®: Biopharmaceutical Products in the U.S. and European Markets
Biosimilars/Biobetters Pipeline Directory (Biosimilarspipeline.com): The most extensive biosimilars (and biobetters, biogenerics, etc.) pipeline information resource
U.S. BIOPHARMACOPEIA™ Registry of Biopharmaceuticals Products: Nomenclature and an online registry of biopharmaceuticals, including biosimilars [proposed]
Earlier products:

Antiviral Agents Bulletin: For 15 years (1987-2003) the only periodical specializing in antiviral drug and vaccine development (32 pages/month; over 5,700 pages plus online database)
Federal Bio-Technology Transfer Directory: all federal, e.g., NIH, inventions and technology transfers in the biomedical/biotechnology areas (687-page book in 1994; online database to 2000)

BII is currently concentrating on divesting its IP.

BIOPHARMA®: Biopharmaceutical Products in the U.S. and European Markets

The only substantive (over 2,000 pages equivalent) reference (database, formerly multi-volume book) concerning biopharmaceutical products
Emphasis on products' biotechnology and commerical aspects
In-depth descriptive and analytical monographs, with in-depth indexing and relational links
Free online public database (partial entries)
Recognized as the essential reference for all concerned with biopharmaceuticals - See the reviews.
Individual and corporate Web database subsccriptions available at reasonable rates

Earlier works authored by R. Rader published by the Biotechnology Information Institute:

Antiviral Agents Bulletin

- from April 1988 to March 2003

For 15 years, the Antiviral Agents Bulletin was the only periodical specializing in the research, development and commercialization of antiviral and HIV therapeutics and vaccines. Over 5,500 pages, published monthly, 32 pages/issue, each year the Bulletin presented over 400 in-depth news articles plus hundreds of U.S patents and international patent disclosures and other information, with in-depth annual indexes and reviews.

Federal Bio-Technology Transfer Directory - 678-page book published in 1994; online database until early 2000. Abstracted/indexed all federal laboratory (e.g., NIH) patents/applications, licenses granted and Collaborative Research and Development Agreements (CRADAs) in the biomedical, biotechnology and pharmaceutical areas.

Consulting: The Biotechnology Information Institute offers consulting, specializing in information retrieval and analysis, competitive intelligence, technology assessment, market research and information resources development/publishing concerning biotechnology and pharmaceutical products, research, development, technologies, patents/technology transfer, marketing and public affairs. See Mr. Rader's bio and full resume
Contact information:

Ronald A. Rader
President
Biotechnology Information Institute
Rockville, MD 20852
Phone: 301-424-0255
E-mail: biotech@bioinfo.com
Phone is the preferred and most reliable contact method.